ChemicalBook > CAS DataBase List > Brolucizumab

Brolucizumab

Product Name
Brolucizumab
CAS No.
1531589-13-5
Chemical Name
Brolucizumab
Synonyms
Brolucizumab;Research Grade Brolucizumab;Research Grade Brolucizumab (DHD12603)
CBNumber
CB58080928
Formula Weight
0
MOL File
Mol file
More
Less

Brolucizumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Brolucizumab Chemical Properties,Usage,Production

Uses

Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment with low picomolar affinity (KD=1.05 pM). Brolucizumab can be used for the research of cancer[1][2].

in vivo

Brolucizumab (15 mg/kg; i.p. 5 days per week for 21 or 41 days) slows the growth of mSLK-KSHV xenograft tumors[2].
Brolucizumab (5-50 mg/kg; i.p. once or twice daily for 28 days) delays in vivo tumor growth in U87MG glioma models[1].
Brolucizumab (10 mg/kg; i.v.) shows a half-life of 5.4-7.8 minutes for the rapid decline phase and 1.4-1.9 hours for the slow decline phase in mice[2].

Animal Model:NSG mice were subcutaneously injected with mSLK-KSHV cell suspension[2]
Dosage:15 mg/kg
Administration:I.p. 5 days per week for 21 or 41 days
Result:Significantly lowed tumor growth there was no difference in survival between experimental and combined control groups.

References

[1] Szabó E, et, al. Antitumor Activity of DLX1008, an Anti-VEGFA Antibody Fragment with Low Picomolar Affinity, in Human Glioma Models. J Pharmacol Exp Ther. 2018 May;365(2):422-429. DOI:10.1124/jpet.117.246249
[2] Eason AB, et, al. DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma. PLoS One. 2020 May 14;15(5):e0233116. DOI:10.1371/journal.pone.0233116

Brolucizumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Brolucizumab Suppliers

ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24963
Advantage
58
Biolab Reagents
Tel
65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
6896
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58
Shanghai jerryxing Biomedical Technology Co., Ltd
Tel
17721492509; 17721492509
Email
643638326@qq.com
Country
China
ProdList
4977
Advantage
58
Changsha Fuzhen Biotechnology Co.,LTD
Tel
15111215862 15111215862
Email
3062105966@qq.com
Country
China
ProdList
4191
Advantage
58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd
Tel
17316404525 17316404525
Email
209533805@qq.com
Country
China
ProdList
9792
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
9998
Advantage
58

1531589-13-5, BrolucizumabRelated Search:


  • Brolucizumab
  • Research Grade Brolucizumab (DHD12603)
  • Research Grade Brolucizumab
  • 1531589-13-5